High density lipoprotein (HDL) cholesterol
Showing 1 - 25 of >10,000
HDL Trial in Nashville (CardioLux™HDL, Placebo)
Active, not recruiting
- HDL
- CardioLux™HDL
- Placebo
-
Nashville, TennesseeHypertension Institute
Apr 4, 2022
Dyslipidemia, Atherosclerosis, Acute Coronary Syndrome Trial in Dallas (RVX000222, Placebo)
Completed
- Dyslipidemia
- +3 more
- RVX000222
- Placebo
-
Dallas, TexasCovance Clinical Research Unit, Inc.
Nov 1, 2022
Serum Adropin to Testosterone and Adiponectin in Obese Men
Completed
- Obesity
- Dyslipidemias
- lipid profile: Total cholesterol (TC), triglycerides (TG), low density lipoprotein (LDL) and high density lipoprotein (HDL))
- +3 more
-
Aswan, EgyptAswan University Hospital
Feb 14, 2022
Intra-abdominal Fat, Metabolic Syndrome, High Cholesterol Trial in United States (Intervention Daily Avocado)
Completed
- Intra-abdominal Fat
- +13 more
- Intervention Daily Avocado
-
Loma Linda, California
- +3 more
Jan 28, 2022
Prevalence of Hyperandrogenism in Type 1 Diabetes
Recruiting
- Type 1 Diabetes
- +5 more
- Clinical hyperandrogenism assessment
- +20 more
-
Madrid, SpainHospital Universitario Ramón y Cajal
Mar 14, 2022
Predictor of No-reflow in Diabetic Patients
Not yet recruiting
- Acute Myocardial Infarction (AMI)
- 1- LDL-C (low-density lipoprotein cholesterol)| and HDL-C(high-density lipoprotein cholesterol) Ratio. 2- Glycemia will be assessed : RBS ( random blood sugar ) . 3- S
- (no location specified)
Apr 7, 2021
No-Reflow Phenomenon Trial (1- LDL-C (low-density lipoprotein cholesterol)| and HDL-C(high-density lipoprotein cholesterol)
Not yet recruiting
- No-Reflow Phenomenon
- 1- LDL-C (low-density lipoprotein cholesterol)| and HDL-C(high-density lipoprotein cholesterol) Ratio. 2- Glycemia will be assessed : RBS ( random blood sugar ) . 3- S
- (no location specified)
Apr 13, 2021
Primary Hypercholesterolemia or Mixed Dyslipidemia Trial (Inclisiran, Matching Placebo for Inclisiran)
Not yet recruiting
- Primary Hypercholesterolemia or Mixed Dyslipidemia
- Inclisiran
- Matching Placebo for Inclisiran
- (no location specified)
May 24, 2023
To Reduce the LDL-C Level in Hypercholesteremia Adult Patients, Combination for Subgroup High LDL-c Patients With Other
Not yet recruiting
- To Reduce the LDL-C Level in Hypercholesteremia Adult Patients
- Combination for Subgroup High LDL-c Patients With Other Comorbidities
- RN0191 INJECTION
- (no location specified)
Jun 14, 2023
Elevated Low-Density Lipoprotein Cholesterol Trial in Herston, Adelaide, Melbourne (SNK-396 - SAD cohort, SNK-396 - MAD Cohort)
Recruiting
- Elevated Low-Density Lipoprotein Cholesterol
- SNK-396 - SAD cohort
- SNK-396 - MAD Cohort
-
Herston, Queensland, Australia
- +2 more
Jun 6, 2023
High Density Lipoprotein Function in Type 1 Diabetic Nephropathy
Recruiting
- Type 1 Diabetes
- Blood samples
- Urine sample
-
Dijon, FranceChu Dijon Bourogne
Jun 8, 2022
OLOMAX for Blood Pressure and Low-density Lipoprotein
Recruiting
- Hypertension
- Dyslipidemias
- Olmesartan Medoxomil/ Amlodipine Besylate/ Rosuvastatin Ca
-
Seoul, Korea, Republic ofSeoul St.Mary's Hospital
Dec 13, 2022
Coronary Artery Diseasse Trial in Seoul (fixed high potent statin therapy, targeted LDL-C goal statin)
Active, not recruiting
- Coronary Artery Diseasse
- fixed high potent statin therapy
- targeted LDL-C goal statin
-
Seoul, Korea, Republic ofDivision of Cardiology, Department of Internal Medicine, Yonsei
Jul 19, 2022
Inclisiran Among Early Users in Germany
Completed
- High Levels of Low-density Lipoprotein Cholesterol
-
Basel, SwitzerlandNovartis
May 12, 2023
Lipid Profile in Acute Coronary Syndrome
Not yet recruiting
- Acute Coronary Syndrome
- Triglycerides/high density lipoprotein ratio
- (no location specified)
Nov 17, 2021
Categories and Attaining LDL-C Targets in Middle Eastern Adults
Not yet recruiting
- Atherosclerotic Cardiovascular Risk
- Low-density-lipoprotein (LDL) Cholesterol
- (no location specified)
Feb 16, 2023
COVID-19 Stress Syndrome, COVID-19 Vaccine Adverse Reaction, COVID-19-Associated Thromboembolism Trial in Chongqing
Active, not recruiting
- COVID-19 Stress Syndrome
- +5 more
- Atorvastatin Calcium Tablets
-
Chongqing, Chongqing, ChinaResidential Address
May 1, 2023
Dyslipidemia Trial in Davis (Krill Oil, Lutein, Nicotinic acid)
Active, not recruiting
- Dyslipidemia
- Krill Oil
- +4 more
-
Davis, CaliforniaUC Davis, Ragle Human Nutrition Center
Aug 9, 2021
Decrease in Paraoxonase Enzyme Level and Myocardial Infarction
Completed
- Myocardial Infarction
- High-Density Lipoid Deficiency
- paraoxanase enzyme level
-
Istanbul, Eyalet/Yerleşke, TurkeyBezmialem vakif university
May 27, 2022
Lipids Trial in Pisa (Low fat/cholesterol diet, High fat/cholesterol diet)
Completed
- Lipids
- Low fat/cholesterol diet
- High fat/cholesterol diet
-
Pisa, PI, ItalyAzienda Ospedaliero-Universitaria Pisana
Dec 16, 2021
Function of High Density Lipoproteins in Acute Coronary
Active, not recruiting
- Acute Coronary Syndrome
-
Montreal, Quebec, CanadaMcGill University Health Centre
Sep 22, 2021
Hypercholesterolemia Trial in Adelaide (Swisse Nutra+ Cholesterol Balance, Placebo)
Completed
- Hypercholesterolemia
- Swisse Nutra+ Cholesterol Balance
- Placebo
-
Adelaide, South Australia, AustraliaCSIRO Nutrition and Health Research Clinic
Mar 9, 2022
Liver Failure Trial in Antalya
Completed
- Liver Failure
-
Antalya, TurkeyAkdenizU
Jul 13, 2023
Healthy Trial (Mango, vanilla wafers)
Not yet recruiting
- Healthy
- Mango
- vanilla wafers
- (no location specified)
Sep 7, 2023